Correlation Between Eyenovia and Artelo Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Artelo Biosciences, you can compare the effects of market volatilities on Eyenovia and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Artelo Biosciences.

Diversification Opportunities for Eyenovia and Artelo Biosciences

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Eyenovia and Artelo is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Eyenovia i.e., Eyenovia and Artelo Biosciences go up and down completely randomly.

Pair Corralation between Eyenovia and Artelo Biosciences

Given the investment horizon of 90 days Eyenovia is expected to under-perform the Artelo Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Eyenovia is 2.88 times less risky than Artelo Biosciences. The stock trades about -0.09 of its potential returns per unit of risk. The Artelo Biosciences is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1.50  in Artelo Biosciences on November 3, 2024 and sell it today you would lose (0.94) from holding Artelo Biosciences or give up 62.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy20.56%
ValuesDaily Returns

Eyenovia  vs.  Artelo Biosciences

 Performance 
       Timeline  
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Artelo Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable essential indicators, Artelo Biosciences is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Eyenovia and Artelo Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyenovia and Artelo Biosciences

The main advantage of trading using opposite Eyenovia and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.
The idea behind Eyenovia and Artelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals